Diarrhea (peds): Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "==Diagnosis==" to "==Evaluation==") |
Neil.m.young (talk | contribs) (Text replacement - " ==" to "==") |
||
| Line 62: | Line 62: | ||
==Evaluation== | ==Evaluation== | ||
==Treatment == | ==Treatment== | ||
===General Treatment=== | ===General Treatment=== | ||
*If bloody diarrhea, use caution with beginning antibioitics in ED before stool culture results | *If bloody diarrhea, use caution with beginning antibioitics in ED before stool culture results | ||
| Line 105: | Line 105: | ||
|} | |} | ||
==See Also == | ==See Also== | ||
*[[Diarrhea]] | *[[Diarrhea]] | ||
*[[Dehydration (peds)]] | *[[Dehydration (peds)]] | ||
| Line 111: | Line 111: | ||
*[[Acute gastroenteritis (peds)]] | *[[Acute gastroenteritis (peds)]] | ||
==References == | ==References== | ||
[[Category:Pediatrics]] [[Category:ID]] [[Category:GI]] | [[Category:Pediatrics]] [[Category:ID]] [[Category:GI]] | ||
Revision as of 23:00, 3 August 2016
Background
Clinical Features
Differential Diagnosis
Infection
- Viral
- Rotavirus
- Norwalk virus
- Enteroviruses
- Adenoviruses
- Bacterial
- Parasitic
Dietary disturbances
- Overfeeding
- Food allergy
- Starvation stools
Anatomic abnormalities
- Intussusception
- Hirschsprung disease
- Partial obstruction
- Appendicitis
- Blind loop syndrome
- Intestinal lymphangiectasia
- Short bowel syndrome
Malabsorption or secretory diseases
- Cystic fibrosis
- Celiac disease
- Disaccharidase deficiency
- Secretory neoplasms
Systemic diseases
- Immunodeficiency
- Endocrinopathy
- Hyperthyroidism
- Hypoparathyroidism
- Congenital adrenal hyperplasia
Miscellaneous
- Inflammatory bowel disease
- Antibiotic-associated diarrhea
- Secondary lactase deficiency
- Irritable colon syndrome
- Neonatal drug withdrawal
- Toxins
- Hemolytic uremic syndrome
Evaluation
Treatment
General Treatment
- If bloody diarrhea, use caution with beginning antibioitics in ED before stool culture results
- Some studies demonstrate antibiotic treatment in setting of E.coli O157:H7 leads to increasing risk of hemolytic uremic syndrome (HUS)
Diarrheal Pathogens in Children and Specific Therapy
| AGENT | SPECIFIC THERAPY BEYOND SUPPORTIVE CARE |
|---|---|
| Campylobacter jejuni | Azithromycin 12mg/kg/day PO for 5 days or |
| Erythromycin 30–50mg/kg/day, divided, tid PO for 5–7 days | |
| Clostridium difficile | Metronidazole 30mg/kg/day, divided, qid PO for 7–10 days or |
| Escherichia coli | Azithromycin 12mg/kg/day PO for 5 days or |
| Trimethoprim-sulfamethoxazole 10mg (TMP)/kg/day PO divided bid for 5–7 days | |
| Giardia lamblia | Metronidazole 15mg/kg/day PO, divided, tid for 5 days |
| Salmonella species | In toxic infants <3 mo: Ampicillin 200mg/kg/24 hours q6h for 7–10 days and Gentamicin 5–7.5mg/kg/24 hours q8h IV |
| Shigella species | Azithromycin 12mg/kg/day PO for 5 days or |
| Trimethoprim-sulfamethoxazole 10mg (TMP)/kg/day, divided, bid for 5–7 days if susceptible | |
| Yersinia enterocolitica | If patient is immunosuppressed, treat as for presumed sepsis |
| Vibrio cholera | None; severe diarrhea or cholera may benefit from antibiotics |